These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7591292)

  • 1. The essential role of endogenous IFN alpha/beta in the anti-metastatic action of sensitized T lymphocytes in mice injected with Friend erythroleukemia cells.
    Gresser I; Maury C; Kaido T; Bandu MT; Tovey MG; Maunoury MT; Fantuzzi L; Gessani S; Greco G; Belardelli F
    Int J Cancer; 1995 Nov; 63(5):726-31. PubMed ID: 7591292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitized T lymphocytes render DBA/2 beige mice responsive to IFN alpha/beta therapy of Friend erythroleukemia visceral metastases.
    Kaido T; Gresser I; Maury C; Maunoury MT; Vignaux F; Belardelli F
    Int J Cancer; 1993 May; 54(3):475-81. PubMed ID: 8509222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of IFN alpha/beta with host cells essential to the early inhibition of Friend erythroleukemia visceral metastases in mice.
    Gresser I; Kaido T; Maury C; Woodrow D; Moss J; Belardelli F
    Int J Cancer; 1994 May; 57(4):604-11. PubMed ID: 8181864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Friend leukemia cell visceral metastases by a new monoclonal antibody and role of the immune system of the host in its action.
    Sala A; Gresser I; Chassoux D; Maury C; Santodonato L; Eid P; Maunoury MT; Barca S; Cianfriglia M; Belardelli F
    Cancer Res; 1992 May; 52(10):2880-9. PubMed ID: 1581903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host CD4+ T lymphocytes are required for the synergistic action of interferon-alpha/beta and adoptively transferred immune cells in the inhibition of visceral ESb metastases.
    Kaido TJ; Maury C; Gresser I
    Cancer Res; 1995 Dec; 55(24):6133-9. PubMed ID: 8521404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend erythroleukemia cells. VIII. Role of the immune system in the inhibition of visceral metastases.
    Gresser I; Maury C; Carnaud C; De Maeyer E; Maunoury MT; Belardelli F
    Int J Cancer; 1990 Sep; 46(3):468-74. PubMed ID: 2394514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host humoral and cellular immune mechanisms in the continued suppression of Friend erythroleukemia metastases after interferon alpha/beta treatment in mice.
    Gresser I; Carnaud C; Maury C; Sala A; Eid P; Woodrow D; Maunoury MT; Belardelli F
    J Exp Med; 1991 May; 173(5):1193-203. PubMed ID: 2022926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful immunotherapy of the highly metastatic murine ESb lymphoma with sensitized CD8+ T cells and IFN-alpha/beta.
    Kaido T; Maury C; Schirrmacher V; Gresser I
    Int J Cancer; 1994 May; 57(4):538-43. PubMed ID: 8181857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody to mouse interferon alpha/beta abrogates resistance to the multiplication of Friend erythroleukemia cells in the livers of allogeneic mice.
    Gresser I; Maury C; Vignaux F; Haller O; Belardelli F; Tovey MG
    J Exp Med; 1988 Oct; 168(4):1271-91. PubMed ID: 3171480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local and systemic response of mice to interferon-alpha 1-transfected Friend leukemia cells.
    Gabriele L; Kaido T; Woodrow D; Moss J; Ferrantini M; Proletti E; Santodonato L; Rozera C; Maury C; Belardelli F
    Am J Pathol; 1995 Aug; 147(2):445-60. PubMed ID: 7639337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of mouse alpha/beta-interferon of the multiplication of alpha/beta-interferon-resistant Friend erythroleukemia cells cocultured with mouse hepatocytes.
    Yasui H; Proietti E; Vignaux F; Eid P; Gresser I
    Cancer Res; 1990 Jun; 50(12):3533-9. PubMed ID: 2140290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.
    Ferrantini M; Proietti E; Santodonato L; Gabriele L; Peretti M; Plavec I; Meyer F; Kaido T; Gresser I; Belardelli F
    Cancer Res; 1993 Mar; 53(5):1107-12. PubMed ID: 8439955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cure of mice with established metastatic friend leukemia cell tumors by a combined therapy with tumor cells expressing both interferon-alpha 1 and herpes simplex thymidine kinase followed by ganciclovir.
    Santodonato L; Ferrantini M; Gabriele L; Proietti E; Venditti M; Musiani P; Modesti A; Modica A; Lupton SD; Belardelli F
    Hum Gene Ther; 1996 Jan; 7(1):1-10. PubMed ID: 8825863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic anti-tumor effects of combined IL-1/IFN-alpha/beta therapy in mice injected with metastatic Friend erythroleukemia cells.
    Belardelli F; Gabriele L; Proietti E; Sestili P; Peretti M; Rozera C; Gresser I
    Int J Cancer; 1991 Sep; 49(2):274-8. PubMed ID: 1879971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the expression of H-2 antigens in non-metastatic and highly metastatic Friend erythroleukemia cells: correlation with the in vivo behaviour of tumor cells.
    Ferrantini M; Pulciani S; Proietti E; Lespinats G; Anastasi A; Ciolli V; Rizza P; Belardelli F
    Clin Exp Metastasis; 1989; 7(6):609-25. PubMed ID: 2476272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined interleukin 1/interleukin 2 therapy of mice injected with highly metastatic Friend leukemia cells: host antitumor mechanisms and marked effects on established metastases.
    Ciolli V; Gabriele L; Sestili P; Varano F; Proietti E; Gresser I; Testa U; Montesoro E; Bulgarini D; Mariani G
    J Exp Med; 1991 Feb; 173(2):313-22. PubMed ID: 1671080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A radiosensitive T-lymphocyte associated with resistance of DBA/2 mice harboring Friend leukemia virus-dormant infections to transplantable Friend leukemia virus-erythroleukemia cells.
    DiCicco LM; Truitt GA; Wheelock EF
    Cancer Res; 1986 Jan; 46(1):127-32. PubMed ID: 3509990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of interferon alpha in the resistance of allogeneic C57B1/6 mice to the multiplication of Friend erythroleukemia cells in the liver.
    Gresser I; Maury C; Bandu MT; Belardelli F
    Int J Cancer; 1990 Feb; 45(2):364-71. PubMed ID: 2406205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon treatment markedly inhibits the development of tumor metastases in the liver and spleen and increases survival time of mice after intravenous inoculation of Friend erythroleukemia cells.
    Gresser I; Maury C; Woodrow D; Moss J; Grütter MG; Vignaux F; Belardelli F; Maunoury MT
    Int J Cancer; 1988 Jan; 41(1):135-42. PubMed ID: 3422071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal administration of IFN-alpha/beta inhibits the development of visceral tumor metastases.
    Kaido TJ
    J Interferon Cytokine Res; 1997 Jan; 17(1):31-6. PubMed ID: 9041469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.